{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:48:46Z","timestamp":1790228926937,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["42-478\/2013 SR"],"award-info":[{"award-number":["42-478\/2013 SR"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microb Cell Fact"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>An increasing rate of antibiotic resistance among Gram-negative bacterial pathogens has created an urgent need to discover novel therapeutic agents to combat infectious diseases. Use of bacteriocins as therapeutic agents has immense potential due to their high potency and mode of action different from that of conventional antibiotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this study, a novel bacteriocin E20c of molecular weight 6.5\u00a0kDa was purified and characterized from the probiotic strain of\n                      <jats:italic>Enterococcus hirae<\/jats:italic>\n                      . E20c had bactericidal activities against several multidrug resistant (MDR) Gram-negative bacterial pathogens. Flow cytometry and scanning electron microscopy studies showed that it killed the\n                      <jats:italic>Salmonella enterica<\/jats:italic>\n                      cells by forming ion-permeable channels in the cell membrane leading to enhanced cell membrane permeability. Further, checkerboard titrations showed that E20c had synergistic interaction with antibiotics such as ampicillin, penicillin, ceftriaxone, and ciprofloxacin against a ciprofloxacin- and penicillin-resistant strain of\n                      <jats:italic>S. enterica.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Thus, this study shows the broad spectrum antimicrobial activity of novel enterocin E20c against various MDR pathogens. Further, it highlights the importance of bacteriocins in lowering the minimum inhibitory concentrations of conventional antibiotics when used in combination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12934-020-01352-x","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T06:04:02Z","timestamp":1588572242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Novel enterocin E20c purified from Enterococcus hirae 20c synergised with \u00df-lactams and ciprofloxacin against Salmonella enterica"],"prefix":"10.1186","volume":"19","author":[{"given":"Preeti","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzamil","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2703-170X","authenticated-orcid":false,"given":"Sukhraj","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"issue":"3","key":"1352_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/hs.2014.0088","volume":"13","author":"E Toner","year":"2015","unstructured":"Toner E, Adalja A, Gronvall GK, Cicero A, Inglesby TV. Antimicrobial resistance is a global health emergency. Health Secur. 2015;13(3):153\u20135.","journal-title":"Health Secur."},{"key":"1352_CR2","unstructured":"Pewtrusts. https:\/\/www.pewtrusts.org\/\/media\/assets\/2018\/09\/antibiotics_currently_in_global_clinical_development_sept2018.pdf."},{"issue":"5","key":"1352_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ijantimicag.2015.07.011","volume":"46","author":"VL Cavera","year":"2015","unstructured":"Cavera VL, Arthur TD, Kashtanov D, Chikindas ML. Bacteriocins and their position in the next wave of conventional antibiotics. Int J Antimicrob Agents. 2015;46(5):494\u2013501.","journal-title":"Int J Antimicrob Agents"},{"key":"1352_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.copbio.2017.07.011","volume":"49","author":"ML Chikindas","year":"2018","unstructured":"Chikindas ML, Weeks R, Drider D, Chistyakov VA, Dicks LM. Functions and emerging applications of bacteriocins. Curr Opin Biotechnol. 2018;49:23\u20138.","journal-title":"Curr Opin Biotechnol"},{"key":"1352_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/0890334408317435","volume":"24","author":"L Fern\u00e1ndez","year":"2008","unstructured":"Fern\u00e1ndez L, Delgado S, Herrero H, Maldonado A, Rodr\u00edguez JM. The bacteriocin nisin, an effective agent for the treatment of Staphylococcal mastitis during lactation. J Hum Lact. 2008;24:311\u20136.","journal-title":"J Hum Lact."},{"issue":"9","key":"1352_CR6","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1128\/AAC.00629-07","volume":"51","author":"J Wu","year":"2007","unstructured":"Wu J, Hu S, Cao L. Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob Agents Chemother. 2007;51(9):3131\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1352_CR7","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1128\/AAC.00261-13","volume":"57","author":"H Mathur","year":"2013","unstructured":"Mathur H, O\u2019Connor PM, Hill C, Cotter PD, Ross RP. Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations. Antimicrob Agents Chemother. 2013;57(6):2882\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"1352_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/jac\/dkf190","volume":"50","author":"W Brumfitt","year":"2002","unstructured":"Brumfitt W, Salton MR, Hamilton-Miller JM. Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J Antimicrob Chemother. 2002;50:731\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"1352_CR9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3389\/fmicb.2017.01205","volume":"8","author":"H Mathur","year":"2017","unstructured":"Mathur H, Field D, Rea MC, Cotter PD, Hill C, Ross RP. Bacteriocin-antimicrobial synergy: a medical and food perspective. Front Microbiol. 2017;8:1205. https:\/\/doi.org\/10.3389\/fmicb.2017.01205.","journal-title":"Front Microbiol."},{"key":"1352_CR10","first-page":"346","volume":"82","author":"JA Crump","year":"2004","unstructured":"Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. 2004;82:346\u201353.","journal-title":"Bull World Health Organ"},{"key":"1352_CR11","unstructured":"WHO. (2018). http:\/\/www.who.int\/mediacentre\/factsheets\/typhoid\/en\/."},{"issue":"4","key":"1352_CR12","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1128\/CMR.00002-15","volume":"28","author":"JA Crump","year":"2015","unstructured":"Crump JA, Sj\u00f6lund-Karlsson M, Gordon MA, Parry CM. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections. Clin Microbiol Rev. 2015;28(4):901\u201337.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"1352_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MOG.0000000000000406","volume":"34","author":"A Karkey","year":"2018","unstructured":"Karkey A, Thwaites GE, Baker S. The evolution of antimicrobial resistance in Salmonella Typhi. Curr Opin Gastroenterol. 2018;34(1):25\u201330.","journal-title":"Curr Opin Gastroenterol."},{"key":"1352_CR14","volume-title":"Global priority list of antibiotic-resistance bacteria to guide research, discovery, and development of new antibiotics","author":"WHO","year":"2017","unstructured":"WHO. Global priority list of antibiotic-resistance bacteria to guide research, discovery, and development of new antibiotics. Geneva: WHO; 2017."},{"key":"1352_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00948","author":"P Sharma","year":"2018","unstructured":"Sharma P, Kaur S, Kaur R, Kaur M, Kaur S. Proteinaceous secretory metabolites of probiotic human commensal Enterococcus hirae 20c, E. faecium 12a and L12b as antiproliferative agents against cancer cell lines. Front Microbiol. 2018. https:\/\/doi.org\/10.3389\/fmicb.2018.00948.","journal-title":"Front Microbiol."},{"issue":"5","key":"1352_CR16","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jmb.2004.03.016","volume":"338","author":"L K\u00e4ll","year":"2004","unstructured":"K\u00e4ll L, Krogh A, Sonnhammer EL. A combined transmembrane topology and signal peptide prediction method. J Mol Biol. 2004;338(5):1027\u201336.","journal-title":"J Mol Biol"},{"issue":"2","key":"1352_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1574-6968.2007.00673.x","volume":"270","author":"J Sanchez","year":"2007","unstructured":"Sanchez J, Diep DB, Herranz C, Nes IF, Cintas LM, Hern\u00e1ndez PE. Amino acid and nucleotide sequence, adjacent genes, and heterologous expression of hiracin JM79, a sec-dependent bacteriocin produced by Enterococcus hirae DCH5, isolated from Mallard ducks (Anas platyrhynchos). FEMS Microbiol Lett. 2007;270(2):227\u201336.","journal-title":"FEMS Microbiol Lett"},{"key":"1352_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12602-016-9217-y","volume":"8","author":"A Gupta","year":"2016","unstructured":"Gupta A, Tiwari SK, Netrebov V, Chikindas ML. Biochemical properties and mechanism of action of enterocin LD3 purified from Enterococcus hirae LD3. Probiotics Antimicrob Proteins. 2016;8:161\u20139.","journal-title":"Probiotics Antimicrob Proteins."},{"key":"1352_CR19","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3389\/fmicb.2015.01543","volume":"6","author":"MP Francino","year":"2016","unstructured":"Francino MP. Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances. Front Microbiol. 2016;6:1543. https:\/\/doi.org\/10.3389\/fmicb.2015.01543.","journal-title":"Front Microbiol."},{"key":"1352_CR20","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1128\/AAC.00887-08","volume":"53","author":"V Kalia","year":"2009","unstructured":"Kalia V, Miglani R, Purnapatre KP, Mathur T, Singhal S, Khan S, Voleti SR, Upadhyay DJ, Saini KS, Rattan A, Raj VS. Mode of action of ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes. Antimicrob Agents Chemother. 2009;53:1427\u201333.","journal-title":"Antimicrob Agents Chemother"},{"key":"1352_CR21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.foodcont.2017.11.042","volume":"86","author":"L Yi","year":"2018","unstructured":"Yi L, Luo L, L\u00fc X. Heterologous expression of two novel bacteriocins produced by Lactobacillus crustorum MN047 and application of BM1157 in control of Listeria monocytogenes. Food Control. 2018;86:374\u201382.","journal-title":"Food Control"},{"key":"1352_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7657190","volume":"2017","author":"H Jiang","year":"2017","unstructured":"Jiang H, Zou J, Cheng H, Fang J, Huang G. Purification, characterization, and mode of action of Pentocin JL-1, a novel bacteriocin isolated from Lactobacillus pentosus, against drug-resistant Staphylococcus aureus. Biomed Res Int. 2017;2017:1. https:\/\/doi.org\/10.1155\/2017\/7657190.","journal-title":"Biomed Res Int"},{"issue":"1","key":"1352_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mimet.2005.10.008","volume":"66","author":"ME Weeks","year":"2006","unstructured":"Weeks ME, von Caron GN, James DC, Smales CM, Robinson GK. Monitoring changes in nisin susceptibility of Listeria monocytogenes Scott A as an indicator of growth phase using FACS. J Microbiol Meth. 2006;66(1):43\u201355.","journal-title":"J Microbiol Meth."},{"issue":"2","key":"1352_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrmicro.2015.3","volume":"14","author":"M Dal Peraro","year":"2016","unstructured":"Dal Peraro M, Van Der Goot FG. Pore-forming toxins: ancient, but never really out of fashion. Nat Rev Microbiol. 2016;14(2):77\u201392.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"1352_CR25","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1128\/AAC.45.3.901-904.2001","volume":"45","author":"C Herranz","year":"2001","unstructured":"Herranz C, Cintas LM, Hern\u00e1ndez PE, Moll GN, Driessen AJ. Enterocin P causes potassium ion efflux from Enterococcus faecium T136 cells. Antimicrob Agents Chemother. 2001;45(3):901\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1352_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1574-6968.2000.tb09362.x","volume":"192","author":"CJ Minahk","year":"2000","unstructured":"Minahk CJ, Far\u00edas ME, Sesma F, Morero RD. Effect of enterocin CRL35 on Listeria monocytogenes cell membrane. FEMS Microbiol Lett. 2000;192(1):79\u201383.","journal-title":"FEMS Microbiol Lett"},{"key":"1352_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10123-002-0063-2","volume":"5","author":"M Dalmau","year":"2002","unstructured":"Dalmau M, Maier E, Mulet N, Vinas M, Benz R. Bacterial membrane injuries induced by lactacin F and nisin. Int Microbiol. 2002;5:73\u201380.","journal-title":"Int Microbiol."},{"issue":"3","key":"1352_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"1352_CR29","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1093\/jac\/dku049","volume":"69","author":"AP Singh","year":"2014","unstructured":"Singh AP, Preet S, Rishi P. Nisin\/\u03b2-lactam adjunct therapy against Salmonella enterica serovar Typhimurium: a mechanistic approach. J Antimicrob Chemother. 2014;69(7):1877\u201387.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1352_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/jac\/dkh079","volume":"53","author":"CJ Minahk","year":"2004","unstructured":"Minahk CJ, Dupuy F, Morero RD. Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35. J Antimicrob Chemother. 2004;53(2):240\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"1352_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3389\/fmicb.2016.00817","volume":"7","author":"AK Al Atya","year":"2016","unstructured":"Al Atya AK, Belguesmia Y, Chataigne G, Ravallec R, Vach\u00e9e A, Szunerits S, et al. Anti-MRSA activities of enterocins DD28 and DD93 and evidences on their role in the inhibition of biofilm formation. Front Microbiol. 2016;7:817. https:\/\/doi.org\/10.3389\/fmicb.2016.00817.","journal-title":"Front Microbiol."},{"issue":"1","key":"1352_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/JB.153.1.232-240.1983","volume":"153","author":"H Nikaido","year":"1983","unstructured":"Nikaido H, Rosenberg EY, Foulds J. Porin channels in Escherichia coli: studies with beta-lactams in intact cells. J Bacteriol. 1983;153(1):232\u201340.","journal-title":"J Bacteriol"},{"key":"1352_CR33","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.bbapap.2008.11.005","volume":"1794","author":"AH Delcour","year":"2009","unstructured":"Delcour AH. Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta Proteins Proteom. 2009;1794:808\u201316.","journal-title":"Biochim Biophys Acta Proteins Proteom."},{"key":"1352_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fcimb.2018.00120","volume":"8","author":"S Kaur","year":"2018","unstructured":"Kaur S, Kaur S, Sharma P, Singh J, Kalia N. Anti-biofilm properties of the faecal probiotic lactobacilli against Vibrio spp. Front Cell Infect Microbiol. 2018;8:120. https:\/\/doi.org\/10.3389\/fcimb.2018.00120.","journal-title":"Front Cell Infect Microbiol."},{"issue":"2","key":"1352_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12602-015-9188-4","volume":"7","author":"S Kaur","year":"2015","unstructured":"Kaur S, Sharma P. Protease-sensitive inhibitory activity of cell-free supernatant of Lactobacillus crispatus 156 synergizes with ciprofloxacin, moxifloxacin and streptomycin against Pseudomonas aeruginosa: an in vitro study. Probiotics Antimicrob Proteins. 2015;7(2):172\u201380.","journal-title":"Probiotics Antimicrob Proteins."},{"key":"1352_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u201354.","journal-title":"Anal Biochem"},{"issue":"5259","key":"1352_CR37","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680\u20135.","journal-title":"Nature"},{"key":"1352_CR38","first-page":"241","volume":"19","author":"DC Dezwaan","year":"2007","unstructured":"Dezwaan DC, Mequio MJ, Littell JS, Allen JP, Rossbach S, Pybus V. Purification and characterization of enterocin 62-6, a two-peptide bacteriocin produced by a vaginal strain of\u00a0Enterococcus faecium: potential significance in bacterial vaginosis. Microb Ecol. 2007;19:241\u201350.","journal-title":"Microb Ecol"},{"issue":"11","key":"1352_CR39","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1099\/mic.0.062190-0","volume":"158","author":"AD Paiva","year":"2012","unstructured":"Paiva AD, de Oliveira MD, de Paula SO, Baracat-Pereira MC, Breukink E, Mantovani HC. Toxicity of bovicin HC5 against mammalian cell lines and the role of cholesterol in bacteriocin activity. Microbiology. 2012;158(11):2851\u20138.","journal-title":"Microbiology"},{"issue":"4","key":"1352_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00284-011-0077-0","volume":"64","author":"FO Ru\u00edz","year":"2012","unstructured":"Ru\u00edz FO, Gerbaldo G, Garc\u00eda MJ, Giordano W, Pascual L, Barberis IL. Synergistic effect between two bacteriocin-like inhibitory substances produced by lactobacilli strains with inhibitory activity for Streptococcus agalactiae. Curr Microbiol. 2012;64(4):349\u201356.","journal-title":"Curr Microbiol"},{"key":"1352_CR41","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.bbamem.2010.06.016","volume":"1798","author":"S Joshi","year":"2010","unstructured":"Joshi S, Bisht GS, Rawat DS, Kumar A, Kumar R, Maiti S, et al. Interaction studies of novel cell selective antimicrobial peptides with model membranes and E. coli ATCC 11775. Biochim Biophys Acta Biomembr. 2010;1798:1864\u201375.","journal-title":"Biochim Biophys Acta Biomembr."},{"key":"1352_CR42","doi-asserted-by":"publisher","first-page":"13412","DOI":"10.1038\/srep13412","volume":"5","author":"L Chopra","year":"2015","unstructured":"Chopra L, Singh G, Jena KK, Sahoo DK. Sonorensin: a new bacteriocin with potential of an anti-biofilm agent and a food biopreservative. Sci Rep. 2015;5:13412. https:\/\/doi.org\/10.1038\/srep13412.","journal-title":"Sci Rep."},{"key":"1352_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.22443\/rms.inf.1.33","volume":"10","author":"M Kalab","year":"2008","unstructured":"Kalab M, Yang AF, Chabot D. Conventional scanning electron microscopy of bacteria. Infocus Magazine. 2008;10:42\u201361.","journal-title":"Infocus Magazine."},{"issue":"2","key":"1352_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1128\/AEM.64.2.439-445.1998","volume":"64","author":"O McAuliffe","year":"1998","unstructured":"McAuliffe O, Ryan MP, Ross RP, Hill C, Breeuwer P, Abee T. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Appl Environ Microbiol. 1998;64(2):439\u201345.","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"1352_CR45","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/jac\/dki477","volume":"57","author":"PJ Petersen","year":"2006","unstructured":"Petersen PJ, Labthavikul P, Jones CH, Bradford PA. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother. 2006;57(3):573\u20136.","journal-title":"J Antimicrob Chemother"}],"container-title":["Microbial Cell Factories"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-020-01352-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12934-020-01352-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-020-01352-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T19:28:55Z","timestamp":1620070135000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbialcellfactories.biomedcentral.com\/articles\/10.1186\/s12934-020-01352-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1352"],"URL":"https:\/\/doi.org\/10.1186\/s12934-020-01352-x","relation":{},"ISSN":["1475-2859"],"issn-type":[{"value":"1475-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"19 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For the isolation of RBCs, the blood of healthy volunteers above the age of 18 yrs was drawn after taking their written informed consent. The protocol was approved by the Institutional Human Ethics Committee, Guru Nanak Dev University and performed in accordance with the guidelines of the Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}